1. Home
  2. MBINM vs IMNM Comparison

MBINM vs IMNM Comparison

Compare MBINM & IMNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Merchants Bancorp

MBINM

Merchants Bancorp

N/A

Current Price

$25.05

Market Cap

0.0

Sector

Finance

ML Signal

N/A

Logo Immunome Inc.

IMNM

Immunome Inc.

HOLD

Current Price

$19.36

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MBINM
IMNM
Founded
N/A
2006
Country
United States
United States
Employees
663
N/A
Industry
Major Banks
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
1.8B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
MBINM
IMNM
Price
$25.05
$19.36
Analyst Decision
Strong Buy
Analyst Count
0
9
Target Price
N/A
$26.89
AVG Volume (30 Days)
N/A
1.2M
Earning Date
N/A
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$9,679,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
N/A
$5.15
52 Week High
N/A
$20.80

Technical Indicators

Market Signals
Indicator
MBINM
IMNM
Relative Strength Index (RSI) 61.30 58.69
Support Level $24.83 $18.87
Resistance Level $25.11 $20.80
Average True Range (ATR) 0.18 1.22
MACD 0.04 -0.02
Stochastic Oscillator 84.55 70.80

Price Performance

Historical Comparison
MBINM
IMNM

About MBINM Merchants Bancorp

Merchants Bancorp is a United States based bank holding company. It operates multiple lines of business focusing on FHA (Federal Housing Administration) multi-family housing and healthcare facility financing and servicing, retail and correspondent residential mortgage banking, and traditional community banking. The business segments of the company are: Multi-family Mortgage Banking which originates and services government-sponsored mortgages for multi-family and healthcare facilities; Mortgage Warehousing segment which funds agency-eligible residential loans as well as commercial loans to nondepository financial institutions; and the Banking segment, which generates maximum revenue, and provides various financial products and services to consumers and businesses.

About IMNM Immunome Inc.

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.

Share on Social Networks: